Effective March 31, 2019, FDA will begin operational implementation of an agency reorganization. FDA’s reorganization reflects the agency’s commitment to modernizing its structure to advance its mission to protect and promote public health, and to meet the challenges of rapid innovation across the industries regulated by FDA. The FDA’s reorganization will realign several entities across the agency to promote strategic priorities, and will elevate the role of the centers, offices and field forces.
This organization chart reflects the new structure under which FDA will operate.
To ensure the timely and effective delivery of high quality and cost effective mission support services across the FDA and its centers, and coordinate emergency preparedness and response activities for incidents involving FDA-regulated products across FDA and its stakeholders.
Excellence and innovation in delivering mission support services and emergency preparedness and response, exceeding stakeholder expectations
Office of Operations Staff Offices
Office of Management
Continually and systematically monitor and guide the planning and implementation of FDA administrative operations through planning, analysis, information dissemination, decision support, and technical expertise.
Security and Emergency Management
Develop and implement the agency–wide security policies and programs by providing leadership and guidance to managers and staff on all aspects of security.
Provide advice and assistance to current and former employees in order to help ensure that decisions they make, and actions they take, are not, nor appear to be, tainted by any question of conflict of interest.
For more information contact OOSuggestions@fda.hhs.gov